michigan semaglutide digestive blockage law firm kentucky ileus legal team in louisiana semaglutide office Professor Ana Santos Rutschman semaglutide gastroparesis legal team – semaglutide digestive blockage law office

Tirzepatide is a dual GLP-1/GIP agonist adding insulin sensitization with potentially better gastrointestinal tolerability

Bottom line Wegovy (semaglutide) is a GLP-1 medication that is FDA-approved for individuals living with obesity or overweight

This raises the possibility of GLP-1/GIP/glucagon receptor triagonist becoming a new treatment for the reversal of liver fibrosis in MASH

BPC-157 promotes angiogenesis and accelerates healing of muscles, tendons, ligaments, and the gut lining

This double delay leads to food sitting in the stomach longer, creating more gas and fermentation, and eventually causing discomfort and often stomach pressure